Coherus Oncology, Inc.
← Back to CHRS Overview

Coherus Oncology, Inc. (CHRS)

Price-to-Earnings Ratio History

P/E Ratio (TTM)

-1.51

Financial Fundamentals

CHRSQuarterly Data • 5Y View

Quarterly P/E

QuarterP/E Ratio
2013-03-31-1.00
2013-06-30-1.13
2013-09-30-2.65
2013-12-31-3.89
2014-03-31-2.27
2014-06-30-2.28
2014-09-30-5.25
2014-12-31-2.78
2015-03-31-6.27
2015-06-30-4.63
2015-09-30-2.69
2015-12-31-4.25
2016-03-31-3.18
2016-06-30-2.45
2016-09-303.47
2016-12-31-4.12
2017-03-31-3.43
2017-06-30-3.32
2017-09-30-3.06
2017-12-31-2.62
2018-03-31-3.73
2018-06-30-5.15
2018-09-30-4.67
2018-12-31-2.46
2019-03-31-11.29
2019-06-3016.56
2019-09-307.56
2019-12-318.04
2020-03-318.11
2020-06-305.38
2020-09-3011.76
2020-12-3133.42
2021-03-31-1.54
2021-06-30-8.64
2021-09-30-8.20
2021-12-31-6.65
2022-03-31-2.24
2022-06-30-2.48
2022-09-30-2.02
2022-12-31-2.33
2023-03-31-1.82
2023-06-30-2.18
2023-09-30-2.28
2023-12-31-1.17
2024-03-310.66
2024-06-30-3.66
2024-09-30-2.79
2024-12-31-0.78
2025-03-31-0.41
2025-06-30-0.47
2025-09-30-1.37
2025-12-31-1.15
2026-03-31-1.51

* P/E ratios are calculated using trailing twelve-month (TTM) earnings.

Coherus Oncology, Inc. (CHRS) P/E Ratio History & Valuation Cycles